Navigation Links
Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
Date:5/21/2012

entricular dilation among the comparison group.
  • Marked improvement in functional capacity was observed among implanted patients through 24 months with six-minute walk distances increasing by 131.9 plus or minus 80 meters (p<0.001).
  • A 30-day major adverse event rate of 1.9 percent was demonstrated on an intent-to-treat basis.
  • "From Cardiac Dimensions' inception, we have been focused on delivering a therapeutic modality that effectively addresses FMR via a safe and efficient percutaneous approach," stated David Reuter, M.D., Ph.D., Chief Medical Officer. "With the publication of the TITAN results, we now have substantial evidence that we have achieved this objective. Patients who suffer from FMR are a large and growing population with few viable options for treatment. This manuscript serves as a major step forward in establishing CARILLON as an important therapy, specifically targeted at this debilitating condition. The strength of the data reflects the clinical evolution of the technology and we are pleased to have partnered with some of the leading investigators in the field in achieving these results. As an organization, these data provide us with significant confidence as we initiate commercialization in Europe."

    About CARILLON® Mitral Contour System® Cardiac Dimensions' CARILLON Mitral Contour System combines a proprietary, implantable device with a percutaneous catheter delivery system. The implantable device consists of a proximal anchor and a distal anchor connected by a shaping ribbon. Utilizing the heart's natural structures, the device is intended to reduce mitral annulus dilatation upon deployment, thereby significantly reducing functional mitral regurgitation (FMR). Rapidly delivered via the venous vasculature, CARILLON has the potential to treat most heart failure patients in a minimally invasive fashion. Clinical data suggests that usage is associated with significant reduction in FMR, and s
    '/>"/>

    SOURCE Cardiac Dimensions, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Personalized Medicine - The Genomic Revolution in Cardiac Care
    2. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
    3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
    4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
    5. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
    6. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
    7. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
    8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
    9. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
    10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
    11. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
    (Date:12/19/2014)... 2014 Capnia, Inc. (NASDAQ: ... diagnostics based on its proprietary Sensalyze™ Technology Platform ... financial results for the third quarter and nine ... the completion of our initial public offering (IPO), ... recently initiated CoSense® commercial launch," said Anish Bhatnagar, ...
    (Date:12/19/2014)... LEXINGTON, Ky. , Dec. 18, 2014 Baptist ... United States to receive full Atrial Fibrillation with ... Patient Care (SCPC). Atrial fibrillation is the most ... concern that in some cases can lead to stroke and ... the United States have atrial fibrillation and the ...
    Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
    ... Medivation, Inc.,(Nasdaq: MDVN ) today announced new ... produce broad, clinically meaningful benefits in,Alzheimer,s disease patients ... novel mechanism of action. These data were presented ... at the 2008 Alzheimer,s Association,International Conference on Alzheimer,s ...
    ... Improvement in Cognitive Performance and Global Clinical Status in ... ... Forest Laboratories, Inc.,(NYSE: FRX ) presented today positive Phase ... the 2008,Alzheimer,s Association International Conference on Alzheimer,s Disease,(ICAD). The study evaluated ...
    Cached Medicine Technology:Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease 2Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease 3Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease 4Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease 5Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease 6New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 2New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 3New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 4
    (Date:12/19/2014)... Novellus Healthcare Communications, LLC announces ... Clinics™, an independent journal that provides practical information ... for patients inside the pharmacy and retail clinics. ... optimal access to quality care, Inside Patient Care: ... team treating and coordinating patient care in pharmacies ...
    (Date:12/19/2014)... (PRWEB) December 19, 2014 From November 24, ... teacher training for the year 2014 in its Goa ... this year. Through the Indian winters, from November to March, ... the beautiful beach of Arambol, Goa. The Goa training sessions ... previous intakes of yoga teacher training, the 10th intake is ...
    (Date:12/19/2014)... December 19, 2014 Consilium Staffing, ... the AMSUS Society for Federal Health Professionals annual ... tenens industry to military and federal healthcare providers. ... National Veterans Small Business Engagement (NVSBE) conference last ... to be a vital solution in addressing our ...
    (Date:12/19/2014)... News) -- The tragic death from "rat-bite fever" of a ... pet rodents, according to a report from the U.S. Centers ... rare but potentially fatal illness that should be considered in ... history of rodent exposure is reported," said a team led ... The case outlined in the report occurred in August ...
    (Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Prostaglandin analogue eye ... significantly reduce the risk of vision loss in patients ... British researchers led by David Garway-Heath, of the Moorfields ... tracked outcomes for more than 500 people newly diagnosed ... the disease and one of the leading causes of ...
    Breaking Medicine News(10 mins):Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2
    ... N.J., July 23 The New Jersey,Hospital Association,s ... planning grant for $199,502 from the Robert Wood ... the quality of,healthcare in New Jersey., The ... months whether New,Jersey can be represented in RWJF,s ...
    ... Laura Kolkman, President,Mosaica Partners, a nationally recognized ... to serve as Chair of the Healthcare,Information ... (HIE) Steering Committee., The HIE Steering ... including providers, payers, vendors, consultants and life,sciences, ...
    ... is a central component of engaging in conversation, but people ... a social interaction. New research from Carnegie Mellon University sheds ... social difficulties in autism, and on the workings of these ... to the study, which is available on the Web site ...
    ... software has recently added advanced features like shared whiteboard, chat and screen ... only available for a high cost with paid services like Webex. Also ... you log into your home or office PC from anywhere on the ... ...
    ... from Napa Valley and North Coast Appellations is offering the first ... providing excellent value for the fine wine consumer and collector. ... ... 2008 -- Fairhope Vintners, a producer of classically styled wines from ...
    ... (ACCP) invites journalists from around the world to ... assembly, held October 25-30, in Philadelphia, PA. CHEST ... clinical chest medicine, including pulmonology, critical care, cardiology, ... address, session topics, special events, or Philadelphia tourism, ...
    Cached Medicine News:Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2Health News:Autism's social struggles due to disrupted communication networks in brain 2Health News:How to Conduct Free Web Meetings and Remote Desktop? 2Health News:Fairhope Vintners Offers First Release of Classically Styled Napa Valley Cabernet Sauvignon Wines 2Health News:Fairhope Vintners Offers First Release of Classically Styled Napa Valley Cabernet Sauvignon Wines 3Health News:CHEST 2008 Philadelphia: Media registration open 2
    ... Constructed of optical steel base metal ... design provides enhanced durability. Includes adjustable non-slip ... 662S Metalite comes with custom fitted lead ... to the front lenses for increased scatter ...
    ... optical steel base metal ... with custom fitted lead ... a seal to the ... scatter radiation protection. Includes ...
    ... Properly manufactured radiation protective eyewear can ... high quality frames and materials offer the ... Our lenses are made of Schott RS-520 ... standards. Most Pulse Glasses are offered with ...
    ... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
    Medicine Products: